The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Investigators conducted a systematic review and meta-analysis of more than 100 studies primarily from Asia, Europe, and the US to evaluate hepatocellular carcinoma outcomes on the basis of age.

WEDNESDAY, March 19, 2025 (HealthDay News) -- For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation ...

Researchers found that statin use decreased the risk for hepatocellular carcinoma and hepatic decompensation, which is an advanced stage of liver disease. The authors found that statin use appeare ...

Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary ...

Abstract and Introduction Risk Factors for HCC in the Absence of HBV or HCV Infection Prevention of Nonviral Liver Disease-related HCC References The mechanisms by which alcohol contributes to HCC ...

For example, damage from the hepatitis B or C virus, or long term alcohol drinking above the recommended levels or non alcoholic fatty liver disease. Hepatocellular carcinoma is more likely to develop ...

One study explored the use of statins, a class of medications typically used to lower LDL cholesterol levels to reduce the risk of stroke and heart disease. Researchers found that statin use decreased ...

The analysis included 16,501 participants: 3610 statin users and 12,891 nonusers. HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for ...

Statin users had a significantly lower 10-year cumulative incidence of hepatocellular carcinoma and hepatic decompensation.